Adagrasib
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Adagrasib, covering 2024-12-16 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) [Phase 3]